Literature DB >> 2735037

Wegener's granulomatosis.

K E Sack.   

Abstract

These discussions are selected from the weekly staff conferences in the Department of Medicine, University of California, San Francisco. Taken from transcriptions, they are prepared by Homer A. Boushey, MD, Professor of Medicine, and John G. Fitz, MD, Assistant Professor of Medicine, under the direction of Lloyd H. Smith, Jr, MD, Professor of Medicine and Associate Dean in the School of Medicine. Requests for reprints should be sent to the Department of Medicine, University of California, San Francisco, School of Medicine, San Francisco, CA 94143.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2735037      PMCID: PMC1026456     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  41 in total

1.  Wegener's granulomatosis.

Authors:  J L FAHEY; E LEONARD; J CHURG; G GODMAN
Journal:  Am J Med       Date:  1954-08       Impact factor: 4.965

2.  Wegener's granulomatosis.

Authors:  S M Wolff; A S Fauci; R G Horn; D C Dale
Journal:  Ann Intern Med       Date:  1974-10       Impact factor: 25.391

3.  Failure of cyclophosphamide to prevent cerebritis in Wegener's granulomatosis.

Authors:  O C Kroneman; M Pevzner
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

4.  HLA antigen frequencies in systemic vasculitis: increase in HLA-DR2 in Wegener's granulomatosis.

Authors:  K B Elkon; D C Sutherland; A J Rees; G R Hughes; J R Batchelor
Journal:  Arthritis Rheum       Date:  1983-01

5.  [Diffuse interstitial fibrosis of the lung in Hodgkin's disease treated by high doses of endoxan].

Authors:  R André; H Rochant; B Dreyfus; G Duhamel; J C Péchère
Journal:  Bull Mem Soc Med Hop Paris       Date:  1967 Nov 3-10

Review 6.  Clinical pharmacology and toxicology of cyclophosphamide: emphasis on use in rheumatic diseases.

Authors:  J Kovarsky
Journal:  Semin Arthritis Rheum       Date:  1983-05       Impact factor: 5.532

7.  Cardiac complications of Wegener granulomatosis: a case report of complete heart block and review of the literature.

Authors:  J Z Forstot; P A Overlie; G K Neufeld; C E Harmon; S L Forstot
Journal:  Semin Arthritis Rheum       Date:  1980-11       Impact factor: 5.532

8.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 16-1981.

Authors: 
Journal:  N Engl J Med       Date:  1981-04-16       Impact factor: 91.245

9.  Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases.

Authors:  R G Palmer; C J Dore; A M Denman
Journal:  Q J Med       Date:  1986-04

10.  Rheumatic manifestations of Wegener's granulomatosis.

Authors:  D T Noritake; S R Weiner; L W Bassett; H E Paulus; R Weisbart
Journal:  J Rheumatol       Date:  1987-10       Impact factor: 4.666

View more
  1 in total

1.  Successful remission induction with a combination therapy of rituximab, cyclophosphamide, and steroids in a patient with refractory optic neuritis in Wegener's granulomatosis.

Authors:  Cord Huchzermeyer; Christian Mardin; Leonard Holbach; Jochen Zwerina; Georg Schett; Jürgen Rech
Journal:  Clin Rheumatol       Date:  2010-09-23       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.